摘要
急性肺栓塞(APE)是临床常见的、正确诊断率较低但病死率较高的疾病之一。中医诊断属"脉痹"范畴。发病原因主要包括血栓栓塞、空气栓塞、脂肪栓塞等,但临床上最为常见的是肺动脉及其分支的血栓栓塞,栓子主要来自下肢深静脉血栓栓子脱落。APE西医药物治疗方式主要包括溶栓治疗、抗凝治疗。而中药有效治疗方式仍处于探索阶段,目前主要采用活血化瘀的中药制剂或方剂,通过改善血液高凝状态,促进血栓的溶解和炎症吸收来达到治疗目的。文章归纳阐述近年来中西医药物治疗急性肺栓塞的研究进展。
Acute pulmonary embolism(APE) is one of the most common clinical diseases with a lower correct diagnosis rate and a higher mortality rate.Chinese medicine diagnosis categorizes it into pulse paralysis.The main triggers of the disease include thromboembolism,air embolism and fat embolism.However,the most common clinical cause is pulmonary thromboembolism and its branches,emboli mainly from deep venous thrombosis of the extremities.APE Western meidical treatment includes thrombolytic therapy,anticoagulant therapy.Nonetheless,the effective treatment of traditional Chinese medicine is still in the exploratory stage.The treatment mainly uses traditional Chinese medicine or prescription that prompts blood circulation,aiming to improve blood hypercoagulability and promote the dissolution of thrombus and inflammatory absorption to achieve the purpose of treatment.
作者
胡俊晟
倪振华
李梦帆
王雄彪
HU Junsheng;NI Zhenhua;LI Mengfan;WANG Xiongbiao(Putuo Hospital Affiliated to Shanghai University of TCM,Shanghai 200062,China)
出处
《辽宁中医杂志》
CAS
2019年第1期201-204,共4页
Liaoning Journal of Traditional Chinese Medicine
基金
上海市普陀区临床重点专科建设项目
上海市普陀区领军人才项目
普陀区中心医院科研创新计划(2013GQ006I)
培英人才计划(2013SR1262)
国家自然科学基金(81402988)
关键词
急性肺栓塞
抗凝治疗
溶栓治疗
中西医结合
活血化瘀中药
acute pulmonary embolism
thrombolytic therapy
anticoagulant therapy
western and Chinese medicine
Chinese medicine for promoting blood circulation
